ToolGen

Bio & Pharma ToolGen gets FDA approval for TGT-001 as ODD

South Korean genome editing developer ToolGen Inc. announced on Monday that its application for orphan drug designation (ODD) of the gene correction...

Bio & Pharma S.Korea's ToolGen develops gene-edited cow for artificial blood

South Korean genome editing developer ToolGen Inc. has teamed up with Lartbio Technology, a Seoul-based transgenic animal development company, to de...

Bio & Pharma ToolGen, ANLBIO to jointly develop progeria treatments

South Korea's two biotech startups ToolGen Incorporated and ANLBIO on Tuesday signed a joint research and development agreement for developing proge...